Enzyme Linked Immunosorbent Assay (ELISA)
- Ready to use
- High reproducibility and lot-to-to lot consistency achieved by testing with native quality controls
- QCs included in the kit
Laboratory markers crosslinking obesity, insulin resistance, diabetes, high blood pressure and impaired lipid metabolism.
Retinol-Binding Protein 4 (RBP4), Epidermal FABP (EFABP, FABP5), Liver FABP (LFABP, FABP1), Galectin-3, ANGPTL-4, Apo M, IGFBP-7, Zinc-Alpha-2-Glycoprotein
Acute kidney injury and chronic kidney disease markers.
KIM-1, FGF-23, Galectin-3, Beta-2-microglobulin, IGFBP-7, RBP4, Urinary Trypsin Inhibitor
Lung disease markers to diagnose and manage respiratory tract infections, COPD, IPF, sarcoidosis and pneumonia.
Markers of bone formation and resorption. Rheumatoid arthritis and osteoarthritis.
Infection, immunity, reproduction and endocrinology, oxidative stress.
Monomeric C-reactive protein, Anti-Mullerian Hormone (AMH, MIS), MMP-2, MMP-3, MMP-9, Alpha-Fetoprotein (AFP), D-dimer, Serum Amyloid A (SAA), Beta-2 microglobulin
BioLab Assays Ltd. is a dynamic life-science company that develops, manufactures and sells innovative and original ready-to-use ELISA (enzyme-linked immunosorbent assay) kits. Our portfolio includes solid phase 96-well ELIS designed for quantitative measurement of cytokines, acute reactant proteins or chemokines, and optimalised for serum, plasma, urine, saliva or CSF samples. BioLab Assays also provides custom immunoassay development and contract manufacturing services to the diagnostic and research industry.
read more30. 11. 2023
BACKGROUND Krebs von den Lungen-6 (KL-6) is a high-molecular mucin-like glycoprotein, encoded by MUC1 gene. KL-6/MUC1 regulates cell-cell...
22. 06. 2022
Meijers et al have published review „Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study...